Resetpharma

2 known investors

Reset Pharma is a neuro-biotechnology company developing first-in-class, psilocybin-inspired therapies aimed at treating demoralization syndrome and psychological trauma in people facing life-altering diseases such as cancer. It works to improve mental health by targeting neural networks, in collaboration with research institutions including a worldwide license from NYU.